Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,168,760 papers from all fields of science
Search
Sign In
Create Free Account
Tafamidis meglumine
Known as:
D-Glucitol, 1-Deoxy-1-(Methylamino)-, 2-(3,5-Dichlorophenyl)-6-Benzoxazolecarboxylate (1:1)
, D-Gluco-2,3,4,5,6-Pentahydroxy-N-Methylhexan-1-Aminium 2-(3,5-Dichlorophenyl)Benzoxazole-6-Carboxylate
A soft gelatin capsule formulation containing the meglumine salt form of tafamidis, a small molecule and pharmacological chaperone with potential…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Narrower (1)
Fx-1006A
TAFAMIDIS MEGLUMINE 20 mg ORAL CAPSULE [Vyndaqel]
tafamidis
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Patient profile with ATTR-FAP and evaluation of the safety and efficacy of tafamidis meglumine in Japan – interim analysis in post-marketing surveillance
T. Ishii
,
Y. Sekijima
,
Y. Ando
Amyloid: Journal of Protein Folding Disorders
2019
Corpus ID: 198491548
Transthyretin familial amyloid polyneuropathy (ATTR-FAP) is a fatal hereditary amyloidosis characterized by extracellular…
Expand
2019
2019
1169Interim analysis of data from a long-term, extension trial of tafamidis meglumine in patients with transthyretin amyloid cardiomyopathy
P. Elliott
,
B. Drachman
,
+8 authors
Sanjiv J. Shah
European Heart Journal
2019
Corpus ID: 208487021
Transthyretin amyloid cardiomyopathy (ATTR-CM), is an underdiagnosed, fatal disease caused by the deposition of…
Expand
2019
2019
Studie ATTR-ACT: přelom v léčbě transthyretinové srdeční amyloidózy
T. Paleček
,
J. Krejčí
2019
Corpus ID: 198066621
Ke klinicky relevantnĂmu postiĹženĂ srdce mohou vĂSst AL (light-chain) amyloidĂlza Ai transthyretinovĂĄ amyloidĂlza (ATTR…
Expand
2018
2018
Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathy
Yasuhiro Shintani
,
A. Okada
,
+14 authors
C. Izumi
ESC Heart Failure
2018
Corpus ID: 53732656
Tafamidis meglumine, a transthyretin (TTR) stabilizer, is effective in delaying the progression of neuropathy in TTR amyloidosis…
Expand
2018
2018
Spezifisches Medikament bessert Prognose
de
MMW - Fortschritte der Medizin
2018
Corpus ID: 195342867
Es ist ein therapeutischer Durchbruch: Patienten mit kardialer Transthyretin-Amyloidose reduzieren ihr Sterberisiko deutlich…
Expand
2013
2013
Neurological Data Collection Protocol On Tafamidis Meglumine Treatment For Familial Amyloid Polyneuropathy: Preliminary Data On Patients Enrolled By The Italian Network
M. Russo
,
L. Obici
,
+18 authors
D. Pareyson
2013
Corpus ID: 79777265
2012
2012
1382 LONG-TERM EFFECTS OF TAFAMIDIS - A NEW THERAPEUTIC OPTION FOR PATIENTS WITH TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY (TTR-FAP)
T. Coelho
,
L. Maia
,
+9 authors
D. Grogan
2012
Corpus ID: 74594116
2011
2011
Vyndaqel, INN-Tafamidis
2011
Corpus ID: 52107192
2009
2009
Spotlight focuses on protein-misfolding therapies
M. Ratner
Nature Biotechnology
2009
Corpus ID: 11765756
A new drug candidate has, for the first time, modified disease progression in patients with a rare inherited proteinmisfolding…
Expand
2009
2009
Pfizer lured to Sweden
S. Aldridge
Nature Biotechnology
2009
Corpus ID: 40222084
A new drug candidate has, for the first time, modified disease progression in patients with a rare inherited proteinmisfolding…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE